Advertisement
IXJ or VHT or XLV
Which ETF would AI Choose? iShares Global Healthcare ETF (IXJ) vs. Vanguard Health Care ETF (VHT) vs. Health Care Select Sector SPDR Fund (XLV)
Key Takeaways
- IXJ offers global healthcare exposure through the S&P Global 1200 Health Care (Sector) Capped Index, with approximately 109 holdings and a higher expense ratio of 0.38%.
- VHT provides broad U.S. healthcare coverage via the MSCI US Investable Market Health Care 25/50 Index, holding over 400 securities and featuring a low expense ratio of 0.09%.
- XLV tracks the Health Care Select Sector Index of the S&P 500, maintaining a concentrated portfolio of about 60 large-cap U.S. holdings with the lowest expense ratio at 0.08%.
- Structural differences center on geographic scope and concentration: IXJ adds international diversification while VHT and XLV remain U.S.-centric with varying levels of holding breadth.
- Cost efficiency favors VHT and XLV for long-term investors, whereas IXJ suits those seeking worldwide sector representation at a premium fee.
- All three ETFs employ passive indexing strategies with periodic rebalancing aligned to their respective benchmarks, emphasizing large-cap pharmaceutical, biotechnology, and medical equipment firms.
Introduction
Investors comparing healthcare sector exposure often evaluate IXJ, VHT, and XLV because these exchange-traded funds (ETFs) deliver targeted access to the same thematic area through distinct index methodologies. IXJ extends coverage beyond U.S. borders, while VHT and XLV focus exclusively on domestic companies. The trio represents a spectrum of approaches: global diversification in IXJ, broad U.S. market-cap inclusion in VHT, and concentrated large-cap selection in XLV. This comparison highlights how differences in index construction, holding counts, and expense structures influence risk, cost, and positioning within the healthcare theme amid ongoing sector dynamics.
iShares Global Healthcare ETF (IXJ) Overview
The iShares Global Healthcare ETF (IXJ) seeks to track the S&P Global 1200 Health Care (Sector) Capped Index, which measures performance of global healthcare companies deemed important to worldwide markets. The fund holds approximately 109 equities, with top positions including Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), UnitedHealth Group (UNH), and Merck (MRK). Sector allocation concentrates in pharmaceuticals, biotechnology, and life sciences (around 71%) alongside health care equipment and services (about 29%). The expense ratio stands at 0.38%. IXJ employs a passive, market-cap-weighted strategy with representative sampling and semi-annual rebalancing. Its distinguishing feature is international exposure, primarily U.S.-dominated yet including developed-market names from Europe and elsewhere.
Vanguard Health Care ETF (VHT) Overview
The Vanguard Health Care ETF (VHT) aims to replicate the MSCI US Investable Market Health Care 25/50 Index, encompassing large-, mid-, and small-cap U.S. healthcare stocks. It maintains over 400 holdings, led by Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck (MRK), and UnitedHealth Group (UNH). Subsector weights emphasize pharmaceuticals (roughly 34%), biotechnology (23%), and health care equipment (15%). The expense ratio is 0.09%. VHT follows a passive, full-replication approach where feasible, with quarterly dividend distributions and quarterly index rebalancing. Its key trait is comprehensive U.S. market-cap coverage, extending beyond mega-caps into smaller healthcare firms.
Health Care Select Sector SPDR Fund (XLV) Overview
The Health Care Select Sector SPDR Fund (XLV) tracks the Health Care Select Sector Index, representing the healthcare component of the S&P 500. The ETF contains approximately 60 holdings, with leading positions in Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck (MRK), and UnitedHealth Group (UNH). Allocation favors pharmaceuticals and biotechnology alongside equipment and services providers. The expense ratio measures 0.08%. XLV uses a passive replication strategy with quarterly rebalancing tied to the S&P methodology. Its primary characteristic is high concentration in S&P 500 healthcare constituents, delivering focused large-cap U.S. exposure.
Industry and Thematic Landscape
The healthcare sector continues to experience steady capital allocation driven by innovation in pharmaceuticals, biotechnology, and medical technology. Macroeconomic factors such as aging populations, regulatory developments around drug pricing, and advancements in personalized medicine influence earnings trends across major holdings. Geopolitical considerations and supply-chain resilience affect global participants more than purely domestic ones. Recent market cycles have highlighted sensitivity to interest-rate environments and broader equity sentiment, with large-cap names often demonstrating relative stability compared to smaller or international peers. Sector risks include policy shifts, patent expirations, and competition from emerging therapies, shaping the external backdrop for all three ETFs regardless of their specific geographic or concentration profiles.
Performance and Positioning Comparison
In recent months and market cycles, structural variances have produced measurable differences in behavior. IXJ’s global reach introduces modest additional currency and regional exposure, potentially moderating or amplifying volatility relative to purely domestic peers depending on international market conditions. VHT’s broader holding base across market capitalizations offers greater diversification depth, which can temper concentration risk compared with XLV’s more focused large-cap selection. XLV typically exhibits tighter tracking to mega-cap healthcare leaders, leading to distinct sensitivity during periods when top-weighted names dominate sector returns. Expense differentials compound over longer horizons, while rebalancing methodologies ensure each fund maintains fidelity to its benchmark without active intervention. Relative positioning therefore hinges on investor preference for geographic breadth versus cost efficiency and holding concentration.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.
Tickeron AI Verdict
Based on observable characteristics, Tickeron’s AI would currently assign a modest probabilistic preference to VHT. Its combination of extensive diversification across hundreds of U.S. healthcare holdings, competitive expense ratio, and balanced market-cap exposure supports favorable risk-adjusted positioning relative to the more concentrated XLV and the higher-cost global IXJ. Structural strength in breadth and cost efficiency underpins this assessment within the current sector environment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IXJ in upward trend: 10-day moving average moved above 50-day moving average on October 19, 2026
The 10-day moving average for IXJ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on IXJ as a result. In 68 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for IXJ just turned positive on October 12, 2026. Looking at past instances where IXJ's MACD turned positive, the stock continued to rise in 41 of 49 cases over the following month. The odds of a continued upward trend are 84%.
IXJ moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in 260 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
IXJ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IXJ entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
VHT in +4.04% Uptrend, rising for three consecutive days on October 15, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VHT advanced for three days, in 255 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on VHT as a result. In 69 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for VHT just turned positive on October 12, 2026. Looking at past instances where VHT's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
VHT moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VHT crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
The 10-day RSI Indicator for VHT moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 27 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
VHT broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VHT entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
XLV in upward trend: price rose above 50-day moving average on October 09, 2026
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 75 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 223 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
XLV broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| IXJ | VHT | XLV | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 1 day ago 73% | 2 days ago 84% |
| Stochastic ODDS (%) | 2 days ago 76% | 1 day ago 76% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 74% | 1 day ago 78% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 84% | 1 day ago 80% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 79% | 1 day ago 79% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 80% | 1 day ago 81% | 2 days ago 84% |
| Advances ODDS (%) | 9 days ago 80% | 9 days ago 81% | 9 days ago 81% |
| Declines ODDS (%) | 5 days ago 77% | 5 days ago 82% | 5 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 79% | 1 day ago 90% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 89% | 1 day ago 89% | 2 days ago 82% |
Advertisement
IXJ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IXJ has been closely correlated with LLY. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IXJ jumps, then LLY could also see price increases.
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IFED | 46.51 | 0.75 | +1.65% |
| ETRACS IFED Invest with the Fed TR Index ETN due September 15, 2061 (IFED) | |||
| CGDG | 38.04 | 0.11 | +0.29% |
| Capital Group Dividend Growers ETF (CGDG) | |||
| FDHY | 47.78 | 0.05 | +0.10% |
| Fidelity Enhanced High Yield ETF (FDHY) | |||
| ASGM | 33.17 | N/A | N/A |
| Virtus AlphaSimplex Global Macro ETF (ASGM) | |||
| EMKT | 28.76 | -0.96 | -3.22% |
| Lazard Emerging Markets Opportunities ETF (EMKT) | |||